NRC Health
NRC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0000070487
No open-market purchases or sales by NRC Health insiders were filed in the last 90 days; 123 institutions reported holding it in 13F filings for Q2 2026, worth $231.9M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in NRC Health as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- +7 vs. Q3 2022
- Shares held
- 11.7M
- +988.0K (+9.2%) vs. Q3 2022
- Total value
- $437.3M
- +$10.7M (+2.5%) vs. Q3 2022
- New holders
- 12
- 45 more added
- Sold out
- 5
- 43 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 123 | $231.9M |
| Q1 2026 | 121 | $184.2M |
| Q4 2025 | 117 | $201.6M |
| Q3 2025 | 119 | $142.0M |
| Q2 2025 | 126 | $196.1M |
| Q1 2025 | 123 | $147.3M |
| Q4 2024 | 133 | $209.6M |
| Q3 2024 | 138 | $273.5M |
| Q2 2024 | 136 | $280.3M |
| Q1 2024 | 142 | $505.2M |
| Q4 2023 | 132 | $476.7M |
| Q3 2023 | 121 | $538.4M |
| Q2 2023 | 116 | $507.8M |
| Q1 2023 | 125 | $498.7M |
| Q4 2022 | 116 | $437.3M |
| Q3 2022 | 111 | $464.7M |
| Q2 2022 | 110 | $441.0M |
| Q1 2022 | 116 | $456.3M |
| Q4 2021 | 113 | $473.7M |
| Q3 2021 | 109 | $473.7M |
| Q2 2021 | 101 | $514.2M |
| Q1 2021 | 99 | $511.3M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding NRC Health; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Victory Capital Management Inc | 119,981 | $4.48M | 0.01% | +18,566+18.3% | Added |
| Bank of New York Mellon Corp | 130,192 | $4.86M | 0.00% | +36,476+38.9% | Added |
| Northwest & Ethical Investments L.P. | 180,280 | $6.72M | 0.23% | −15,410−7.9% | Reduced |
| Comerica Bank | 159,810 | $6.82M | 0.05% | 00.0% | Unchanged |
| Touchstone Capital, Inc. | 273,730 | $10.2M | 11.92% | −11,775−4.1% | Reduced |
| Northern Trust Corp | 276,934 | $10.3M | 0.00% | +10,761+4.0% | Added |
| Geode Capital Management, LLC | 304,145 | $11.3M | 0.00% | +6,945+2.3% | Added |
| State Street Corp | 313,366 | $11.7M | 0.00% | +9,583+3.2% | Added |
| Renaissance Technologies LLC | 365,284 | $13.6M | 0.02% | −27,800−7.1% | Reduced |
| QV Investors Inc. | 449,870 | $16.8M | 1.61% | −14,450−3.1% | Reduced |
| Dimensional Fund Advisors LP | 629,253 | $23.5M | 0.01% | +923+0.1% | Added |
| Conestoga Capital Advisors, LLC | 727,746 | $27.1M | 0.51% | −3,875−0.5% | Reduced |
| Vanguard Group Inc | 860,427 | $32.1M | 0.00% | +9,174+1.1% | Added |
| Morgan Stanley | 974,253 | $36.3M | 0.00% | +952,230+4,323.8% | Added |
| BlackRock Inc. | 987,554 | $36.8M | 0.00% | +54,628+5.9% | Added |
| Kayne Anderson Rudnick Investment Management LLC | 3,224,165 | $120.3M | 0.38% | −8,830−0.3% | Reduced |
| Mawer Investment Management Ltd. | 0 | $0 | 0.00% | −59,957−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −2,641−100.0% | Sold out |
| Copeland Capital Management, LLC | 0 | $0 | 0.00% | −944−100.0% | Sold out |
| Wolff Wiese Magana LLC | 0 | $0 | 0.00% | −483−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | 0 | Sold out |
| Atlanta Capital Management Co L L C | – | – | – | – | Not filed |
| FourThought Financial, LLC | – | – | – | – | Not filed |